top of page

Mizuho’s Salim Syed returns to BiotechTV for Analyst Thursdays

Salim Syed talks about his recent initiation on CRISPR Therapeutics, and comments on Wave Life Sciences, BridgeBio, Atara, and Cytokinetics.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page